Oscar Health (OSCR) Investor Day 2024 summary
Event summary combining transcript, slides, and related documents.
Investor Day 2024 summary
8 Jul, 2026Vision and strategy
Introduced a dynamic three-year strategic plan, updated annually, focused on achieving at least 20% annual revenue growth and 5% operating margin by 2027, without relying on enhanced subsidies.
Mission centers on making a healthier life accessible and affordable for all, leveraging healthcare and technology expertise.
Four strategic objectives: achieve ~20% revenue CAGR and ~5% operating margin by 2027, enhance member experience, externalize technology, and expand the individual market with ICHRA.
Prioritizing near-term profitability, ACA footprint expansion, and leveraging technology to empower the broader healthcare system.
Compensation for leadership is tied to three-year EBIT targets to ensure alignment with strategic objectives.
Financial guidance and capital allocation
Reaffirmed 2024 guidance: $8.3B–$8.4B revenue, 20.5%–21.0% SG&A ratio, 80.2%–81.2% MLR, and $125M–$175M Adjusted EBITDA.
Long-term targets include 20% revenue CAGR and 5% operating margin by 2027, with EPS expected to exceed $2.25 per share.
Positioned for strong cash flow and capital generation, with ability to self-fund growth and future allocation priorities.
Fixed cost leverage, technology-driven efficiencies, and disciplined pricing are key to margin improvement.
Capital allocation will prioritize organic growth, with flexibility for optimization and potential share buybacks if excess capital persists.
Growth strategy and market expansion
Membership grew 150% since 2021, reaching ~1.5 million as of April 2024, and ACA market share increased from 4% to 7% across 18 states.
Growth pillars: disciplined footprint expansion, innovative products/experiences, and robust total cost of care management.
Plans to expand ACA reach from 50% to 70% by 2027, targeting entry into 150+ new MSAs, with further upside from ICHRA and potential subsidy extensions.
Existing markets expected to drive 50% of incremental growth, new markets 40%, and product innovation (including ICHRA) the remainder.
Product innovation includes culturally tailored offerings, chronic condition plans, and technology-enabled care journeys.
Latest events from Oscar Health
- AI, transparency, and financial incentives are reshaping consumer-driven healthcare strategies.OSCR
7th Annual Healthcare Symposium9 Jul 2026 - Q1 2025 revenue up 42%, net income up 55%, and membership exceeded 2 million.OSCR
Q1 20259 Jul 2026 - 2025 revenue up 28% with record membership; 2026 targets profitability and margin gains.OSCR
Q4 20258 Jul 2026 - Strong 2026 performance, favorable trends, and AI-driven integrity shape a stable outlook.OSCR
Goldman Sachs 47th Annual Global Healthcare Conference 20268 Jun 2026 - Board transitions, robust growth, and all proposals approved; no Q&A from shareholders.OSCR
AGM 20264 Jun 2026 - Revenue and net income soared, membership surged, but regulatory risks persist.OSCR
Q1 20267 May 2026 - Proxy covers director elections, say-on-pay, auditor ratification, and robust governance practices.OSCR
Proxy filing23 Apr 2026 - Votes will be cast on directors, executive pay, and auditor ratification at the June 2026 meeting.OSCR
Proxy filing23 Apr 2026 - Strong 2026 enrollment and robust risk management drive optimism amid regulatory shifts.OSCR
47th Annual Raymond James Institutional Investor Conference2 Mar 2026